Last reviewed · How we verify
Formoterol Inhalant Powder
Formoterol Inhalant Powder is a Small molecule drug developed by Imperial College London. It is currently in Phase 1 development. Also known as: Oxis.
At a glance
| Generic name | Formoterol Inhalant Powder |
|---|---|
| Also known as | Oxis |
| Sponsor | Imperial College London |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control
- VENTURI (VENTilation Using Respiratory Imaging) (PHASE2)
- Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome (NA)
- Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR) (PHASE3)
- Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER® (PHASE3)
- Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10) (NA)
- Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma. (PHASE3)
- Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Formoterol Inhalant Powder CI brief — competitive landscape report
- Formoterol Inhalant Powder updates RSS · CI watch RSS
- Imperial College London portfolio CI
Frequently asked questions about Formoterol Inhalant Powder
What is Formoterol Inhalant Powder?
Formoterol Inhalant Powder is a Small molecule drug developed by Imperial College London.
Who makes Formoterol Inhalant Powder?
Formoterol Inhalant Powder is developed by Imperial College London (see full Imperial College London pipeline at /company/imperial-college-london).
Is Formoterol Inhalant Powder also known as anything else?
Formoterol Inhalant Powder is also known as Oxis.
What development phase is Formoterol Inhalant Powder in?
Formoterol Inhalant Powder is in Phase 1.
Related
- Manufacturer: Imperial College London — full pipeline
- Also known as: Oxis
- Compare: Formoterol Inhalant Powder vs similar drugs
- Pricing: Formoterol Inhalant Powder cost, discount & access